Literature DB >> 28115983

An investigation of bedside laparoscopy in the ICU for cases of non-occlusive mesenteric ischemia.

G Cocorullo1, A Mirabella2, N Falco1, T Fontana1, R Tutino1, L Licari1, G Salamone1, G Scerrino1, G Gulotta1.   

Abstract

BACKGROUND: Acute mesenteric ischemia is a rare affection with high related mortality. NOMI presents the most important diagnostic problems and is related with the higher risk of white laparotomy. This study wants to give a contribution for the validation of laparoscopic approach in case of NOMI.
METHODS: Thirty-two consecutive patients were admitted in last 10 years in ICU of Paolo Giaccone University Hospital of Palermo for AMI. Diagnosis was obtained by multislice CT and selective angiography was done if clinical conditions were permissive. If necrosis was already present or suspected, surgical approach was done. Endovascular or surgical embolectomy was performed when necessary. Twenty NOMI patients underwent medical treatment performing laparoscopy 24 h later to verify the evolution of AMI. A three-port technique was used. In all patients we performed a bed side procedure 48-72 h later in both non-resected and resected group.
RESULTS: In 14 up 20 case of NOMI the disease was extended throughout the splanchnic district, in 6 patients it involved the ileum and the colon; after a first look, only 6 patients underwent resection. One patient died 35 h after diagnosis of NOMI. The second look, 48 h later, demonstrated 4 infarction recurrences in the group of resected patients and onset signs of necrosis in 5 patients of non-resected group. A total of 15 resections were performed on 11 patients. Mortality rate was 6/20-30% but it was much higher in resected group (5/11-45,5%). Non-therapeutic laparotomy was avoided in 9/20 patients and in this group mortality rate was 1/9-11%. No morbidity was recorded related to laparoscopic procedure.
CONCLUSIONS: Laparoscopy could be a feasible and safety surgical approach for management of patient with NOMI. Our retrospective study demonstrates that laparoscopy don't increase morbidity, reduce mortality avoiding non-therapeutic laparotomy.

Entities:  

Keywords:  Acute mesenteric ischemia; Intensive care; Laparoscopy; NOMI; Surgery

Mesh:

Year:  2017        PMID: 28115983      PMCID: PMC5241960          DOI: 10.1186/s13017-017-0118-5

Source DB:  PubMed          Journal:  World J Emerg Surg        ISSN: 1749-7922            Impact factor:   5.469


Background

Acute mesenteric ischemia is a rare affection with high related mortality. It accounts 1:1000 acute hospital admissions in Europe and the USA [1] and presents a very high mortality with a range from 50 to 69% [2-5] of cases. The affection consists in an acute arterial occlusion due to embolism (EAMI), or thrombosis (TAMI), in a venous thrombosis (VAMI) or, at last, in an non-occlusive mesenteric ischemia (NOMI). Pathophysiology is different in each type as risk factors. Different are also comorbidities and clinical findings. In all cases diagnosis is very difficult because there aren’t specific laboratory tests. EAMI is often related to hearth disease (atrial fibrillation, myocardial infarction, etc.) and causes acute symptoms as diarrhoea, vomiting, acute abdominal pain; TAMI is characterized by more indolent onset with post-prandial pain and weight loss in patients with history of atherosclerosis, hypertension, diabetes; VAMI occurs in 10% of cases in patients with hypercoagulable disorders, malignancies, hepatitis, pancreatitis, and other affections causing slow blood flow. NOMI occurs mostly in critically ill patients with hypovolemia, hypotension, recent treatment with beta blockers or alpha adrenergic. Usually these are patients with endotracheal tube and symptoms can start in acute or gradual way. Nowadays the gold standard for diagnosis is CT, which offers a good accuracy in AMI detection with high values of sensitivity and specificity [6], but it is well known that these values are not similar in each etiological type. NOMI is an exclusion diagnosis. It presents the most important diagnostic problems due to lack of specific radiological features on CT, which usually shows a normal bowel wall and a high variability of its contrast enhancement ranging from absent or diminished to increased [7]. So, in the suspicious of NOMI an anamnesis of low arterial flow or low cardiac output (recent cardiac failure, prolonged cardio-pulmonary resuscitation, cardiac surgery, severe cardiac failure, aortic dissection and aneurism, recent aortic vascular surgery etc..), biochemical findings (>TGO/>TGP;> LDL, >CPK, >Bilirubin), signs of Acute Kidney Failure (altered level of creatinine, urea and electrolytes, reduced urine output). When possible a selective angiography or an angio-CT should be performed [8] to confirm diagnosis, exclude other form of AMI and to start the medical treatment (fluid infusion, prostaglandins, etc.) (Fig. 1).
Fig. 1

Procedural Algorithm in case of NOMI in ICU

Procedural Algorithm in case of NOMI in ICU Then NOMI needs a very close follow-up to obtain an early detection of mesenteric infarction which imposes bowel resection. Early diagnosis and prompt intervention are the goals of modern treatment. It can stop the fatal progression of sepsis that is responsible of the high mortality rate [9]. Also, the treatment is different in each type of AMI [10]: resolution of embolism in open surgery (especially if bowel necrosis is present) or in endovascular way is the choice treatment in patients with EAMI or TAMI. In case of VAMI the first choice is anticoagulation and finally in patients with NOMI the first step is the infusion of fluids and vasodilators; the last mentioned are administered directly via Superior Mesenteric Artery (SMA) when possible. If bowel necrosis is present, resection is necessary at the same time [10]. Although CT consents a differential diagnosis in patients with doubtful abdominal presentation and for these reason is the first diagnostic step for these patient, there isn’t any diagnostic test which can early indicate the onset of bowel necrosis. The aim of this study is to show our results of systematic use of laparoscopy in bowel infarction detection in critical ill patients.

Methods

A retrospective study was carried out on 32 consecutive patients recovered in last 10 years (1st January 2006–31st December 2015) in ICU of Paolo Giaccone University Hospital of Palermo. The patients’ age, clinical symptoms, biochemistry and radiological findings were considered. In all patients, AMI was diagnosed by multislice CT (Fig. 2); selective angiography was done if clinical conditions were permissive.
Fig 2

Angio-CT, a case of NOMI: Radiologic Science Department–AOUP Palermo

Angio-CT, a case of NOMI: Radiologic Science Department–AOUP Palermo If necrosis was already present or suspected, surgical approach was done. Moreover, endovascular or surgical embolectomy was performed in cases with EAMI or TAMI whilst VAMI and NOMI patients underwent medical treatment performing laparoscopy 24 h later to verify the evolution of AMI. A three-port technique was used [11, 12]: a 10-mm camera-port was positioned through the umbilical scar. After a first exploration of the abdomen, other two 5 mm operative-trocars were put in the left hypochondrium and in the left iliac fossa. In this way, as in right laparoscopic colectomy, an accurate exploration of entire small bowel was possible starting from the ileocecal junction and going back up to the Treitz ligament. Colon was entirely explored. Only in 4 patients a fourth 5 mm port in right flank was needed. The bowel aspect and the ischemia extension were evaluated; all patients showed widespread intestinal pallor therefore, the first suffering loop was searched (intense pallor, necrosis signs) and the necrotic bowel was resected when present. The involved bowel was mobilized and after vessels ligation it was externalized through a 5–6 cm laparotomy. After resection, no anastomosis was done and an ostomy was performed. The absence of signs of necrosis is not to be underestimated because of the rapid precipitation of NOMI clinical features. Therefore, in all patient medical therapy was continued and EBPM was administered using prophylactic dosages, the procedure was repeated 48–72 h later (Second Look) in both non-resected and resected group, looking for new necrotic areas. Due the organization of our Hospital in nearly but separated departments, a bed-side laparoscopy was performed to avoid the transfer of the critically ill patients to the department of radiology or to operation room that often can leads to serious difficulties especially when the transfers are multiple. A laparoscopic column and a centralized CO2 distribution system are available in ICU and allow the execution of bed side laparoscopy. The availability of mobilizable beds in ICU support the surgeon to perform explorative laparoscopy with low Co2 flow and pressure (8–10 mmHg). Only two surgeons need to perform the procedure and the second or further looks are performed through the same sites used before. A 10-mm optic and two laparoscopic forceps or an ultrasound dissector allow the exploration and the dissection of bowel needs resection (Table 1). In case of re-resection the bowel was extracted trough the same previous incision and after a distal ligation of vessels, resection was performed with linear stapler. Moreover, in all cases ostomy and mucous fistula was is performed.
Table 1

Necessary equipment for bed-side laparoscopy

Laparoscopic Column including: CO2 insufflator, HD camera, light source, HD monitor
Optic 10 mm
N° 2 laparoscopic forceps
Ultrasound dissector with disposable device
N° 3 Trocars (10 mm, 5 mm, 5 mm)
Surgical drapes
Basic Surgical Kit
Safety and efficacy of the procedure was evaluated in terms of mortality, diagnosed infarctions and avoided non-therapeutic laparotomy. Postoperative morbidity was an outcome not reliable due to multiple comorbidity already present in our patients. Necessary equipment for bed-side laparoscopy

Results

Among 32 critical ill patients with CT report of AMI, 6 presented EAMI, 3 TAMI, 1 VAMI and 20 NOMI (Table 2).
Table 2

ICU patients with AMI

ICU patients with AMI (1st January 2006–31 December 2015)
Type of AMIN° of cases
EAMI6
TAMI3
VAMI1
NOMI20
ICU patients with AMI Main biochemical and CT findings of NOMI patients are collected in Table 3. In all NOMI cases (20) an intense pallor of bowel wall was the main laparoscopic finding. In 14 cases, it was extended throughout the splanchnic district, whilst in 6 patients it involved mainly the ileum and the colon (right colon 2 cases; left colon 3 cases; entire colon 1 case); every patient in last group underwent resection to prevent bowel necrosis and peritonitis in 5 cases, whilst in 1 patient bowel resection was necessary to remove a necrotic segment. After a first look only 6 patients underwent bowel resection and its extension was since 15 up to 175 cm. After resection in each patient a stoma and a mucous fistula were performed on the proximal and the distal stump respectively (Table 4).
Table 3

Laboratory and CT findings

PatientsAgeGOT (U/L) nv: 0–31GPT (U/L) nv: 0–31LDH (U/L) nv: 240–480CPK (U/L) nv: 26–192CREATININE mg/dl nv: 0,51–0,95WBC vn 4–11 10^3 uLCT FINDINGS
166520489312512235.126,28negative for SMA obstruction, bowel infarction, peritoneal collections
27961049812252511,322,3negative for SMA obstruction, paralytic ileum signs
37542628613166801,423,6negative for SMA obstruction, paralytic ileum signs
45483877811988891,324,68negative for SMA obstruction, right colon and ileum thickening
581650568221810013,217,42negative for SMA obstruction, diffuse colon and bowel infarction, peritoneal collections
68246659815899961,915,69negative for SMA obstruction, paralytic ileum signs
76183568712867541,7522,65negative for SMA obstruction, right colon and ileum thickening
890589410185710282,614,8negative for SMA obstruction, left colon and ileum thickening
97838052016359872,415,1negative for SMA obstruction, peritoneal collections
10764894758563851,923,2negative for SMA obstruction, bowel infarction
11715545987582352,420,1negative for SMA obstruction, bowel infarction, peritoneal collections
126166568911056241,418,7negative for SMA obstruction, paralytic ileum signs
13788117996582011,214,8negative for SMA obstruction, bowel infarction
1469715684289014253,318,4negative for SMA obstruction, left colon and ileum thickening
1582542396168712152,717,5negative for SMA obstruction, paralytic ileum signs
166949638914208932,618,84negative for SMA obstruction, bowel infarction, peritoneal collections
17786754977523581,526,3negative for SMA obstruction, paralytic ileum signs
1887742694386918454,824.3negative for SMA obstruction, left colon and ileum thickening
197886868810128542,716,4negative for SMA obstruction, paralytic ileum signs
2072308258153610883,737,26negative for SMA obstruction, peritoneal collections
Table 4

Extension of ischemic tract in NOMI patients

Extension of Ischemia In NOMI patients
Bowel siteN° of cases1st look resection cases
Small Bowel and other splancnic organs140
Ileum and right colon22
Left colon33
Entire colon11
Laboratory and CT findings Extension of ischemic tract in NOMI patients Only one non-resected patient died 35 h after diagnosis of NOMI and before the second look for cardiac failure. The second look, 48 h later, demonstrated 4 infarction recurrences in the group of resected patients and the onset of necrosis in 5 patients of non-resected group. A total of 15 resections were performed on 11 patients (Table 5). Mortality rate was 6/20 (30%) but it was much higher in resected group (5/11–45,5%). Non-therapeutic laparotomy was avoided in 9/20 patients (45%) and in this group mortality rate was 1/9 (11,1%). No morbidity was recorded related to laparoscopic procedure (Tables 6 and 7).
Table 5

Recurrent necrosis after second look

Second look evaluation (48 h later)N° of recurrent necrosis
Resected group4
Non-resected group5
Table 6

Outcome of NOMI patients after treatment

Outcome of NOMI patients after treatmentN° of casesResected groupNon resected group
Mortality6/20 (30%)5/11 (45,5%)1/9 (11,1%)
Morbidity related to laparoscopy000
Table 7

Mortality rate

MortalityCases/TOTPercent
First and second look negative1/911,1
1 st look positivity3/650
2 nd look positivity only2/540
Recurrent necrosis after second look Outcome of NOMI patients after treatment Mortality rate

Discussion

NOMI is an infrequent type of AMI and accounts 20% of cases. It is more frequent in critically ill patients and depends on combination of two distinct factors; low cardiac output and vasoconstrictive agents. In literature, there are no high evidences about clinical findings, diagnosis and therapy of AMI and even less about NOMI. It is possible to found some case-series recording the experience of single centres and in this way, the present report is a contribution about diagnostic and therapeutic pathway in critically ill patients with suspicious NOMI. It is well known that decreased mortality for AMI in last years is related to more aggressive therapeutic approach in occlusive shapes like surgical or non-surgical blood flow restoration, resection of necrotic bowel, supportive intensive care. Moreover, the precocity of the treatment is highly related with its success. But if in patients with occlusive forms the operative (surgical or not-surgical) approach ever follows diagnosis of AMI, in NOMI patients the treatment consists of pharmacological therapy with the need of continuous monitoring of ischemia. Only the onset of necrosis will require surgery. Because of the absence of tests that consent a determination of further bowel viability, laparoscopy can represent a diagnostic technique with high potential therapeutic options. We used it in NOMI patients both at the first and the second look to detect and remove dead bowel avoiding certain general and access-related risks associated with laparotomy [13]. Moreover, it is well known how the surgical stress could be life-threatening in these patients, and so to avoid a non-therapeutic laparotomy could be a very important step in their clinical course. In our centre, it was started 10 years ago, routinely use of laparoscopy in critical ill patients presenting clinical and radiological findings suggesting AMI. Laparoscopy was utilized like the last diagnostic procedure and the first therapeutic step. Explorative laparoscopy allowed to avoid 9/20 (45%) non-therapeutic laparotomies and at the same time it showed in 11 cases the presence of bowel necrosis; In 6 patients at the first look and in 9 patients at the second look. Four of second look resected patients had been already resected at the first look. The routinely execution of the second look 48 h after the first exploration of the abdomen is strongly suggested because of pathophysiology of NOMI [14]. The possible occurrence of low cardiac output due to surgical procedures (i.e. blood loss, ECC, etc.), in fact, can cause bowel ischemia but only in a variable percentage of cases necrosis will occur. Then in our experience laparoscopy was positively used in patients with CT-scan diagnosed NOMI both for the first and the second look to detect the eventual onset of bowel necrosis. Its advantages were the possibility of bed-side performing without the surgical stress of laparotomic access.

Conclusions

NOMI represents a frequent type of AMI diagnosis. CT scan represent the golden standard in diagnosis of AMI but has a lower power in defining NOMI forms. Laparoscopy could be a feasible and safety surgical approach for diagnosis of ischaemic tract of bowel and to removing it. Our retrospective study demonstrate that laparoscopy don’t increase morbidity and reduce mortality probably avoiding non-therapeutic laparotomy.
  13 in total

1.  Survival after operations for ischaemic bowel disease.

Authors:  M Wadman; I Syk; S Elmståhl
Journal:  Eur J Surg       Date:  2000-11

Review 2.  CT diagnosis of acute mesenteric ischemia from various causes.

Authors:  Akira Furukawa; Shuzo Kanasaki; Naoaki Kono; Makoto Wakamiya; Toyohiko Tanaka; Masashi Takahashi; Kiyoshi Murata
Journal:  AJR Am J Roentgenol       Date:  2009-02       Impact factor: 3.959

3.  Three-port colectomy: reduced port laparoscopy for general surgeons. A single center experience.

Authors:  Gianfranco Cocorullo; Roberta Tutino; Nicolò Falco; Giuseppe Salamone; Gaspare Gulotta
Journal:  Ann Ital Chir       Date:  2016       Impact factor: 0.766

4.  The abdominal drain. A convenient port for second-look laparoscopy.

Authors:  A H Nassar; T Htwe; H Hefny; Y Kholeif
Journal:  Surg Endosc       Date:  1996-11       Impact factor: 4.584

Review 5.  Acute mesenteric ischemia.

Authors:  R J Stoney; C G Cunningham
Journal:  Surgery       Date:  1993-09       Impact factor: 3.982

6.  Long-term risk of mesenteric ischemia in patients with inflammatory bowel disease: a 13-year nationwide cohort study in an Asian population.

Authors:  Ming-Shian Tsai; Cheng-Li Lin; Hsin-Pao Chen; Po-Huang Lee; Fung-Chang Sung; Chia-Hung Kao
Journal:  Am J Surg       Date:  2014-10-13       Impact factor: 2.565

7.  Acute mesenteric ischemia: causes and mortality rates over sixteen years in southern Iran.

Authors:  Peyman Hassanpour Haghighi; Kamran Bagheri Lankarani; Seyed Alireza Taghavi; Vahid Emad Marvasti
Journal:  Indian J Gastroenterol       Date:  2008 Nov-Dec

8.  Planned second-look laparoscopy in the management of acute mesenteric ischemia.

Authors:  Hakan Yanar; Korhan Taviloglu; Cemalettin Ertekin; Beyza Ozcinar; Fatih Yanar; Recep Guloglu; Mehmet Kurtoglu
Journal:  World J Gastroenterol       Date:  2007-06-28       Impact factor: 5.742

9.  Laparoscopic, three-port and SILS cholecystectomy: a retrospective study.

Authors:  A Agrusa; G Romano; G Cucinella; G Cocorullo; S Bonventre; G Salamone; G Di Buono; G De Vita; G Frazzetta; D Chianetta; V Sorce; G Bellanca; G Gulotta
Journal:  G Chir       Date:  2013 Sep-Oct

10.  Global validation of the WSES Sepsis Severity Score for patients with complicated intra-abdominal infections: a prospective multicentre study (WISS Study).

Authors:  Massimo Sartelli; Fikri M Abu-Zidan; Fausto Catena; Ewen A Griffiths; Salomone Di Saverio; Raul Coimbra; Carlos A Ordoñez; Ari Leppaniemi; Gustavo P Fraga; Federico Coccolini; Ferdinando Agresta; Asrhaf Abbas; Saleh Abdel Kader; John Agboola; Adamu Amhed; Adesina Ajibade; Seckin Akkucuk; Bandar Alharthi; Dimitrios Anyfantakis; Goran Augustin; Gianluca Baiocchi; Miklosh Bala; Oussama Baraket; Savas Bayrak; Giovanni Bellanova; Marcelo A Beltràn; Roberto Bini; Matthew Boal; Andrey V Borodach; Konstantinos Bouliaris; Frederic Branger; Daniele Brunelli; Marco Catani; Asri Che Jusoh; Alain Chichom-Mefire; Gianfranco Cocorullo; Elif Colak; David Costa; Silvia Costa; Yunfeng Cui; Geanina Loredana Curca; Terry Curry; Koray Das; Samir Delibegovic; Zaza Demetrashvili; Isidoro Di Carlo; Nadezda Drozdova; Tamer El Zalabany; Mushira Abdulaziz Enani; Mario Faro; Mahir Gachabayov; Teresa Giménez Maurel; Georgios Gkiokas; Carlos Augusto Gomes; Ricardo Alessandro Teixeira Gonsaga; Gianluca Guercioni; Ali Guner; Sanjay Gupta; Sandra Gutierrez; Martin Hutan; Orestis Ioannidis; Arda Isik; Yoshimitsu Izawa; Sumita A Jain; Mantas Jokubauskas; Aleksandar Karamarkovic; Saila Kauhanen; Robin Kaushik; Jakub Kenig; Vladimir Khokha; Jae Il Kim; Victor Kong; Renol Koshy; Avidyl Krasniqi; Ashok Kshirsagar; Zygimantas Kuliesius; Konstantinos Lasithiotakis; Pedro Leão; Jae Gil Lee; Miguel Leon; Aintzane Lizarazu Pérez; Varut Lohsiriwat; Eudaldo López-Tomassetti Fernandez; Eftychios Lostoridis; Raghuveer Mn; Piotr Major; Athanasios Marinis; Daniele Marrelli; Aleix Martinez-Perez; Sanjay Marwah; Michael McFarlane; Renato Bessa Melo; Cristian Mesina; Nick Michalopoulos; Radu Moldovanu; Ouadii Mouaqit; Akutu Munyika; Ionut Negoi; Ioannis Nikolopoulos; Gabriela Elisa Nita; Iyiade Olaoye; Abdelkarim Omari; Paola Rodríguez Ossa; Zeynep Ozkan; Ramakrishnapillai Padmakumar; Francesco Pata; Gerson Alves Pereira Junior; Jorge Pereira; Tadeja Pintar; Konstantinos Pouggouras; Vinod Prabhu; Stefano Rausei; Miran Rems; Daniel Rios-Cruz; Boris Sakakushev; Maria Luisa Sánchez de Molina; Charampolos Seretis; Vishal Shelat; Romeo Lages Simões; Giovanni Sinibaldi; Matej Skrovina; Dmitry Smirnov; Charalampos Spyropoulos; Jaan Tepp; Tugan Tezcaner; Matti Tolonen; Myftar Torba; Jan Ulrych; Mustafa Yener Uzunoglu; David van Dellen; Gabrielle H van Ramshorst; Giorgio Vasquez; Aurélien Venara; Andras Vereczkei; Nereo Vettoretto; Nutu Vlad; Sanjay Kumar Yadav; Tonguç Utku Yilmaz; Kuo-Ching Yuan; Sanoop Koshy Zachariah; Maurice Zida; Justas Zilinskas; Luca Ansaloni
Journal:  World J Emerg Surg       Date:  2015-12-16       Impact factor: 5.469

View more
  13 in total

1.  Non-Occlusive Mesenteric Ischemia (NOMI) in Parkinson's disease: case report.

Authors:  G Salamone; C Raspanti; L Licari; N Falco; G Rotolo; G Augello; G Melfa; G Gulotta
Journal:  G Chir       Date:  2017 Mar-Apr

2.  Multiparametric evaluation of risk factors associated to seroma formation in abdominal wall surgery.

Authors:  L Licari; G Salamone; Z Parinisi; S Campanella; C Sabatino; G Ciolino; P De Marco; N Falco; S Boventre; G Gulotta
Journal:  G Chir       Date:  2017 Nov-Dec

3.  Deep SSI after mesh-mediated groin hernia repair: management and outcome in an Emergency Surgery Department.

Authors:  G Salamone; L Licari; G Augello; S Campanella; N Falco; R Tutino; G Cocorullo; R Gullo; C Raspanti; P De Marco; C Porrello; G Profita; G Gulotta
Journal:  G Chir       Date:  2017 Jan-Feb

4.  Neuroendocrine tumor of the common bile duct: case report.

Authors:  C Raspanti; N Falco; V Silvestri; G Rotolo; S Bonventre; G Gulotta
Journal:  G Chir       Date:  2016 Nov-Dec

Review 5.  Acute Mesenteric Ischemia.

Authors:  Rebecca J Lendzion; Gert Frahm-Jensen; James Keck
Journal:  Clin Colon Rectal Surg       Date:  2022-08-12

Review 6.  Acute mesenteric ischemia: updated guidelines of the World Society of Emergency Surgery.

Authors:  Miklosh Bala; Fausto Catena; Jeffry Kashuk; Belinda De Simone; Carlos Augusto Gomes; Dieter Weber; Massimo Sartelli; Federico Coccolini; Yoram Kluger; Fikri M Abu-Zidan; Edoardo Picetti; Luca Ansaloni; Goran Augustin; Walter L Biffl; Marco Ceresoli; Osvaldo Chiara; Massimo Chiarugi; Raul Coimbra; Yunfeng Cui; Dimitris Damaskos; Salomone Di Saverio; Joseph M Galante; Vladimir Khokha; Andrew W Kirkpatrick; Kenji Inaba; Ari Leppäniemi; Andrey Litvin; Andrew B Peitzman; Vishal G Shelat; Michael Sugrue; Matti Tolonen; Sandro Rizoli; Ibrahima Sall; Solomon G Beka; Isidoro Di Carlo; Richard Ten Broek; Chirika Mircea; Giovanni Tebala; Michele Pisano; Harry van Goor; Ronald V Maier; Hans Jeekel; Ian Civil; Andreas Hecker; Edward Tan; Kjetil Soreide; Matthew J Lee; Imtiaz Wani; Luigi Bonavina; Mark A Malangoni; Kaoru Koike; George C Velmahos; Gustavo P Fraga; Andreas Fette; Nicola de'Angelis; Zsolt J Balogh; Thomas M Scalea; Gabriele Sganga; Michael D Kelly; Jim Khan; Philip F Stahel; Ernest E Moore
Journal:  World J Emerg Surg       Date:  2022-10-19       Impact factor: 8.165

7.  The abdominal wall incisional hernia repair in cirrhotic patients.

Authors:  L Licari; G Salamone; G Ciolino; S Campanella; Z Parinisi; C Sabatino; F Carfì; S Bonventre; G Gulotta
Journal:  G Chir       Date:  2018 Jan-Feb

Review 8.  Acute mesenteric ischemia: guidelines of the World Society of Emergency Surgery.

Authors:  Miklosh Bala; Jeffry Kashuk; Ernest E Moore; Yoram Kluger; Walter Biffl; Carlos Augusto Gomes; Offir Ben-Ishay; Chen Rubinstein; Zsolt J Balogh; Ian Civil; Federico Coccolini; Ari Leppaniemi; Andrew Peitzman; Luca Ansaloni; Michael Sugrue; Massimo Sartelli; Salomone Di Saverio; Gustavo P Fraga; Fausto Catena
Journal:  World J Emerg Surg       Date:  2017-08-07       Impact factor: 5.469

9.  Endovascular recanalization of occluded superior mesenteric artery using retrograde access through the inferior mesenteric artery.

Authors:  Eduardo Keller Saadi; Gustavo Oderich; Eduardo Medronha; Rodrigo Petersen Saadi; Marina Petersen Saadi; Cristiano Jaegger
Journal:  J Vasc Surg Cases Innov Tech       Date:  2017-07-19

10.  Bedside diagnostic laparoscopy for critically ill patients in the Intensive Care Unit: Retrospective study and review of literature.

Authors:  Giovanni Alemanno; Paolo Prosperi; Annamaria Di Bella; Filippo Socci; Stefano Batacchi; Adriano Peris; Matteo Pieri; Giuseppe Olivo; Pietro Quilghini; Paolo Fontanari; Pierluigi Stefàno; Alessio Giordano; Veronica Iacopini; Carlo Bergamini; Andrea Valeri
Journal:  J Minim Access Surg       Date:  2019 Jan-Mar       Impact factor: 1.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.